Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EuroPCR 24: 5-year Results of the SOLVE-TAVI trial
Author(s): Hans-Josef Feistritzer Added: 11 months ago
EuroPCR 24 - In this succinct interview, we are joined by Dr Hans-Josef Feistritzer (University of Leipzig, DE) to discuss the findings of the SOLVE-TAVI Trial.In recent years, trials such as CHOICE, REPRISE III, the SCOPE trial, PORTICO IDE and the SMART trial have privided increasing evidence for direct TACI valve comparisons as device designs improve. TAVI is increasingly performed using local… View more

Intervention
EuroPCR 24: Ancillary SMART Trial Analyses
Author(s): Roxana Mehran Added: 11 months ago
EuroPCR 24 - Dr Roxana Mehran (Mount Sinai Hospital, US) joins us to discuss the findings from an ancillary analysis of the SMART trial (NCT04722250).The SMART trial is a prospective, multi-center, randomized controlled study that aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve replacement (TAVR) in patients with… View more

Intervention
ESC 24 Hot Line Discussion: The RHEIA Trial
Author(s): Harriette Van Spall , Helene Eltchaninoff Added: 7 months ago
ESC Congress 2024 — Transcatheter aortic valve replacement shows superiority over surgical aortic valve replacement for women with severe aortic stenosis.Host, Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Helene Eltchaninoff (University Hospital of Rouen, FR) to discuss key findings from the RHEIA trial (NCT04160130; Optimapharm).This prospective, randomised study aims to… View more

Demographic

Vascular Disease and Surgery
SMART Trial
Author(s): Didier Tchétché Added: 1 year ago
Dr Didier Tchétché (Clinique Pasteur, Toulouse, FR) joins us to discuss findings from the SMART Trial.This prospective, multi-centre, randomised controlled study aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli and severe symptomatic aortic stenosis. At… View more

Intervention
ACC.24: The SMART Trial
Author(s): Howard C Herrmann Added: 1 year ago
ACC.24 — Investigator, Dr Howard C Hermann (Penn Medicine, Philadelphia, PA, US) joins us to discuss the findings from the SMART Trial (NCT04722250).This prospective, multi-center, randomized controlled study aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve replacement (TAVR) in patients with small aortic annuli… View more

Intervention
Author(s): Hans-Josef Feistritzer , Carlos Collet Added: 11 months ago
Our regular review seriesView From the Thoraxcenter,hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.For short, concise coverage of the key data revealed, our accessibleExpert Interviewswere conducted with select faculty, focussing on the results, applicability… View more

Intervention
Gadolinium-guided Transcatheter Aortic Valve Implantation
Author(s): Bandar Alshehri , Hussein Alamri , Naif Alghasab , et al Added: 2 months ago

Intervention

CV Disease in Special Populations
Anti-thrombotic Therapy Following TAVI: UK and Ireland Consensus Statement
Author(s): Azfar Zaman , Bernard Prendergast , David Hildick-Smith , et al Added: 2 years ago

Anticoagulation